Stock search

Ticker or company name

Agilent Technologies

A · NYSE · Life Sciences Tools & Services

$172,92Down −1,04 (−0,60%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$49,0 bn
Div. yield
0,7%
Year to date
+27,8%
52 weeks: $108,35$182,99

Ratio score

78/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

6 ✓ · 2 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM34,129,737,9
Forward P/E26,0—29,5
PEG3,7—3,7
P/S6,75,76,6
EV/EBITDA26,822,329,9
P/FCF38,7—38,7
P/B6,76,45,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 30 analysts

Buy
22
Hold
8
Sell
0

Beat the EPS forecast in 2 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,521,62Up +6,9%
Q2 20261,441,49Up +3,8%
Q1 20261,401,36Down −2,6%
Q4 20251,621,59Down −1,6%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,88 bn1,84 bn1,80 bn1,86 bn1,74 bn1,67 bn1,68 bn1,70 bn1,58 bn1,57 bn1,66 bn1,69 bn
EPS1,281,201,071,521,180,751,111,230,971,051,181,61
Margin19,3%18,5%17,0%23,3%19,3%12,9%18,9%20,6%17,9%19,6%21,0%28,1%
FCF439 m201 m175 m452 m259 m107 m334 m388 m360 m230 m395 m432 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $1,30 m.

NameAmountSharesPrice
dolsten mikael4 Sep 2026 · sale$95 972634$151,38
dolsten mikael29 May 2026 · sale$216 6721 600$135,42
dolsten mikael1 Dec 2025 · sale$389 5112 600$149,81
gonsalves rodney26 Nov 2025 · sale$464 9563 000$154,99
mcdonnell padraig18 Nov 2025 · sale$130 492911$143,24

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NYSE
Country
US
IPO date
18 Nov 1999

Company description, revenue by segment and region, and the CEO will come later.

Next report
23 Nov 2026, after close

An AI summary of the earnings call will come later.

Peers

CompanyPrice
WATWaters Corporation$453,4229would not consider269,0—1,8%
IQVIQVIA$264,7372would consider31,3+8,8%8,1%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
ILMNIllumina, Inc.$198,0075would consider33,6+5,8%19,7%
WSTWest Pharmaceutical Services$417,8083would consider45,5+12,6%18,8%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.